Adjudicated Cardiovascular Events in Patients With COVID‐19: Association With Vaccination Status and Changes over Time
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.125.044011 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Behnood Bikdeli und 41 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Brigham and Women's Hospital Harvard Medical School Boston MA USA. Hauptthemen laut MEDLINE: COVID-19, Cardiovascular Diseases, Vaccination, COVID-19 Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Patients with COVID‐19 are at risk of thrombotic and cardiovascular complications. Existing risk estimates derive from early COVID‐19 experiences. More recent event rates, temporal trends, and the association between vaccination status and cardiovascular outcomes remain unclear.
Methods
The CORONA‐VTE Network (COVID‐19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications) multicenter registry included patients with COVID‐19 from March 2020 to February 2024. A composite of venous and arterial thrombotic events and a composite of adjudicated cardiovascular events were assessed at 90 days after COVID‐19 diagnosis. Time‐to‐first‐event analyses were stratified by inpatients and outpatients and adjusted for competing risks. Outcomes were adjudicated by independent physicians.
Results
Of 11 165 patients, 4451 were inpatients (mean age, 65 years; 47% women) and 462 of 4451 were admitted to the intensive care unit. Among inpatients, the 90‐day cumulative incidences of thrombotic and cardiovascular events were 8.9% (95% CI, 8.0%–9.8%) and 15.6% (95% CI, 14.5%–16.7%), respectively. Corresponding estimates for patients in the intensive care unit were 20.0% (95% CI, 16.6%–24.0%) and 30.7% (95% CI, 26.8%–35.3%), while event rates were low among outpatients. There was an initial decline in cardiovascular events (adjusted hazard ratio [HR], 0.84; P =0.001) after the first COVID‐19 wave, with a subsequent catch‐up, with no significant linear change in cardiovascular events (adjusted P trend =0.634). Vaccination was associated with a reduced risk of cardiovascular events (adjusted HR, 0.75 [95% CI, 0.62–0.92]; P =0.005).
Conclusions
Thrombotic and cardiovascular events are common in hospitalized patients with COVID‐19, especially those in the intensive care unit, without a persistent decline over time. COVID‐19 vaccination was associated with a reduced risk of cardiovascular events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Brigham and Women's Hospital Harvard Medical School Boston MA USA.
- Thrombosis Research Group, Brigham and Women's Hospital Harvard Medical School Boston MA USA.
- YNHH/Yale Center for Outcomes Research and Evaluation (CORE) New Haven CT USA.
- Department of Medicine, Brigham and Women's Hospital Harvard Medical School Boston MA USA.
- Division of Pulmonary and Critical Care Medicine Massachusetts General Hospital Boston MA USA.
- Department of Cardiology Thomas Jefferson University Hospital Philadelphia PA USA.
ORCID-Profile: Behnood Bikdeli, Darsiya Krishnathasan, Antoine Bejjani, Candrika D Khairani, Umberto Campia, Julia Davies, Nicole Porio, Andre Armero, Anthony Tristani, Victor Nauffal, Zaid I Almarzooq, Eric Q Wei, Sina Rashedi, Alyssa Sato, Valeria Zuluaga-Sánchez, Mehrdad Zarghami, Sirus Jesudasen, Bruce C Tiu, Geno J Merli, Orly Leiva, John Fanikos, Samantha M Rizzo, Shiavax J Rao, Abdelghani El Rafei, Marc P Bonaca, Brett J Carroll, Samuel Z Goldhaber, Gregory Piazza
Zitieren
APA
Bikdeli, B., Krishnathasan, D., Bejjani, A., Khairani, C. D., Hamade, N., Campia, U., Davies, J., Porio, N., Assi, A., Armero, A., Tristani, A., Ortiz-Rios, M. D., Nauffal, V., Almarzooq, Z. I., Wei, E. Q., McGonagle, B., Pfeferman, M., Rashedi, S., Sato, A., …, & CORONA‐VTE Network Investigators (2025). Adjudicated Cardiovascular Events in Patients With COVID‐19: Association With Vaccination Status and Changes over Time. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.044011
Vancouver
Bikdeli B, Krishnathasan D, Bejjani A, Khairani CD, Hamade N, Campia U, et al. Adjudicated Cardiovascular Events in Patients With COVID‐19: Association With Vaccination Status and Changes over Time. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.044011
BibTeX
@article{Bikdeli2025,
author = {Bikdeli, Behnood and Krishnathasan, Darsiya and Bejjani, Antoine and Khairani, Candrika D and Hamade, Nada and Campia, Umberto and Davies, Julia and Porio, Nicole and Assi, Ali and Armero, Andre and Tristani, Anthony and Ortiz-Rios, Marcos D and Nauffal, Victor and Almarzooq, Zaid I and Wei, Eric Q and McGonagle, Bridget and Pfeferman, Mariana and Rashedi, Sina and Sato, Alyssa and Scimeca, Giovanni and Zuluaga-Sánchez, Valeria and Zarghami, Mehrdad and Achanta, Aditya and Jesudasen, Sirus and Tiu, Bruce C and Merli, Geno J and Leiva, Orly and Fanikos, John and Sharma, Aditya M and Rizzo, Samantha M and Morrison, Ruth B and Vishnevsky, Alec and Rao, Shiavax J and Naveh, Sivan and El Rafei, Abdelghani and Welker, James and Bonaca, Marc P and Carroll, Brett J and Goldhaber, Samuel Z and Lan, Zhou and Piazza, Gregory and CORONA‐VTE Network Investigators, CORONA‐VTE Network Investigators},
title = {Adjudicated Cardiovascular Events in Patients With COVID‐19: Association With Vaccination Status and Changes over Time},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.125.044011}
}
EUVIMED